Literature DB >> 12590028

Surveys to assess satisfaction with end-of-life care: does timing matter?

David J Casarett1, Roxane Crowley, Karen B Hirschman.   

Abstract

The goals of this study were to determine whether post-death surveys of family members cause more distress if they are administered closer in time to the patient's death, and whether family members are less likely to respond to earlier surveys. Caregivers of hospice patients were randomly assigned to receive a survey at 2 weeks (n = 107) or at 6 weeks (n = 100) after the patient's death. Response rates and self-reported distress experienced in completing the survey were recorded. There were no differences in self-ratings of distress between 2- and 6-week surveys, and response rates were identical (2-week: 54%; 6-week: 54%). Distress and response rate do not appear to be influenced by the timing of data collection, even when surveys are administered very soon after death.

Entities:  

Mesh:

Year:  2003        PMID: 12590028     DOI: 10.1016/s0885-3924(02)00636-x

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  19 in total

1.  Identifying elements of ICU care that families report as important but unsatisfactory: decision-making, control, and ICU atmosphere.

Authors:  Tristan R Osborn; J Randall Curtis; Elizabeth L Nielsen; Anthony L Back; Sarah E Shannon; Ruth A Engelberg
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

2.  Timing of Survey Administration After Hospice Patient Death: Stability of Bereaved Respondents.

Authors:  Eleanor L DiBiasio; Melissa A Clark; Pedro L Gozalo; Carol Spence; David J Casarett; Joan M Teno
Journal:  J Pain Symptom Manage       Date:  2015-01-31       Impact factor: 3.612

3.  Integrating palliative and critical care: evaluation of a quality-improvement intervention.

Authors:  J Randall Curtis; Patsy D Treece; Elizabeth L Nielsen; Lois Downey; Sarah E Shannon; Theresa Braungardt; Darrell Owens; Kenneth P Steinberg; Ruth A Engelberg
Journal:  Am J Respir Crit Care Med       Date:  2008-05-14       Impact factor: 21.405

4.  Conducting research interviews with bereaved family carers: when do we ask?

Authors:  Brenda Bentley; Moira O'Connor
Journal:  J Palliat Med       Date:  2014-12-17       Impact factor: 2.947

Review 5.  Measuring Experience With End-of-Life Care: A Systematic Literature Review.

Authors:  Jessica Penn Lendon; Sangeeta C Ahluwalia; Anne M Walling; Karl A Lorenz; Oluwatobi A Oluwatola; Rebecca Anhang Price; Denise Quigley; Joan M Teno
Journal:  J Pain Symptom Manage       Date:  2014-12-24       Impact factor: 3.612

6.  Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups With Blood Cancer Patients and Bereaved Caregivers.

Authors:  Catherine Henckel; Anna Revette; Scott F Huntington; James A Tulsky; Gregory A Abel; Oreofe O Odejide
Journal:  J Pain Symptom Manage       Date:  2020-01-09       Impact factor: 3.612

7.  Effect of a quality-improvement intervention on end-of-life care in the intensive care unit: a randomized trial.

Authors:  J Randall Curtis; Elizabeth L Nielsen; Patsy D Treece; Lois Downey; Danae Dotolo; Sarah E Shannon; Anthony L Back; Gordon D Rubenfeld; Ruth A Engelberg
Journal:  Am J Respir Crit Care Med       Date:  2010-09-10       Impact factor: 21.405

8.  Strategies for Enhancing Family Participation in Research in the ICU: Findings From a Qualitative Study.

Authors:  Danae Dotolo; Elizabeth L Nielsen; J Randall Curtis; Ruth A Engelberg
Journal:  J Pain Symptom Manage       Date:  2017-04-22       Impact factor: 3.612

9.  Potential for response bias in family surveys about end-of-life care in the ICU.

Authors:  Erin K Kross; Ruth A Engelberg; Sarah E Shannon; J Randall Curtis
Journal:  Chest       Date:  2009-07-17       Impact factor: 9.410

10.  Duration of withdrawal of life support in the intensive care unit and association with family satisfaction.

Authors:  Eric Gerstel; Ruth A Engelberg; Thomas Koepsell; J Randall Curtis
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.